Research programme: respiratory tract infection therapeutics - Inimmune
Latest Information Update: 15 Jan 2024
At a glance
- Originator Inimmune
- Class Anti-infectives
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Respiratory tract infections
Most Recent Events
- 10 Oct 2023 Early research in Respiratory tract infections in USA (Intranasal) prior October 2023 (Inimmune pipeline, October 2023)